Surgery Partners Inc (SGRY) — Capital Reinvestment Ratio

Latest as of September 2025: 0.24x

Surgery Partners Inc (SGRY) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow ($83.60 Million) in capital expenditures ($19.80 Million). Check Surgery Partners Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

$83.60 Million
USD

Capital Expenditures

$19.80 Million
USD

Data as of

Sep 2025
Most recent filing

Surgery Partners Inc Capital Reinvestment Ratio (2012–2024)

This chart tracks Surgery Partners Inc's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see SGRY operating cash flow.

Annual Capital Reinvestment Ratio for Surgery Partners Inc (2012–2024)

Year-by-year Capital Reinvestment Ratio for Surgery Partners Inc from 2012 to 2024. See SGRY free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.30x $300.10 Million $90.40 Million ▼ -0.3%
2023 0.30x $293.80 Million $88.80 Million ▼ -40.5%
2022 0.51x $158.80 Million $80.60 Million ▼ -23.2%
2021 0.66x $87.10 Million $57.60 Million ▲ +280.6%
2020 0.17x $246.90 Million $42.90 Million ▼ -69.4%
2019 0.57x $129.50 Million $73.60 Million ▲ +106.5%
2018 0.28x $144.60 Million $39.80 Million ▲ +12.5%
2017 0.24x $120.94 Million $29.60 Million ▼ -21.6%
2016 0.31x $125.24 Million $39.11 Million ▼ -21.1%
2015 0.40x $84.48 Million $33.44 Million ▼ -7.9%
2014 0.43x $21.95 Million $9.44 Million ▲ +408.4%
2013 0.08x $49.08 Million $4.15 Million ▼ -16.5%
2012 0.10x $46.38 Million $4.69 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow